Table 1.
Category | Contents | Age (yr) |
Parents (mother) | ||
---|---|---|---|---|---|
≥19 | 7-18 | 0-6 | |||
Food survey | ○ | ||||
Food | Market-based sampling | ○ | ○ | ○ | ○ |
Health-functional food | Sampling from subjects | ○ | ○ | ○ | ○ |
Herbal medicines | Sampling from subjects | ○ | ○ | ○ | ○ |
Dietary survey | 24-Hour recall | ○ | ○ | ○ | ○ |
FFQ | ○ | ○ | ○ | ○ | |
History of infant feeding | ○ | ○ | |||
Intake status of functional food | ○ | ○ | ○ | ○ | |
Intake status of herbal medicines | ○ | ○ | ○ | ||
Dietary behaviora | ○ | ○ | |||
Biomonitoring | |||||
Blood | Lead, cadmium, mercury | ○ | ○ | ○ | ○ |
12-H our urine | BPA, cadmium, phthalateb | ○ | ○ | ○ | ○ |
Aflatoxinc | ○ | ||||
Physical examination | |||||
BMI and physical index | Blood pressure, body weight, height, waist, hip, BMI | ○ | ○ | ○ | ○ |
Biomarkers | |||||
General hematology | WBC, RBC hemoglobin, hematocrit, platelet | ○ | ○ | ○ | ○ |
Renal function index | Total protein, sGOT, sGPT, γ-GTP, BUN, creatinine | ○ | ○ | ||
Renal damage | NAG, β2-microglobulin | ○ | ○ | ||
Lipids | Cholesterol, triglyceride, HDL-c , LDL-c | ○ | ○ | ○ | ○ |
Immunological index | CRP, IgE | ○ | ○ | ○ | ○ |
Body iron status | Serum Fe, TIBC, UBIC, ferritin | ○ | ○ | ○ | ○ |
Metabolism and endocrine index | C-peptide, glucose, insulin | ○ | ○ | ○ | ○ |
Oxidative stress damages | Malondialdehyde | ○ | ○ | ○ | |
Bone impact | Bone density | ○ | ○ |
FFQ, food frequency questionnaire; BMI, body mass index; WBC, white blood cell; RBC, red blood cell; sGOT, serum glutamic oxaloacetate; sGPT, serum glutamic pyruvate transaminase; γ-GTP, gamma-glutamic transpeptidase; BUN, blood urea nitrogen; NAG, N-acetyl-β-D-glucosaminidase; HDL-c, high-density lipoproteincholesterol; LDL-c, low-density lipoprotein-cholesterol; CRP, C-reactive protein; IgE, immunoglobulin E; Fe, iron; TIBC, total iron binding capacity; UBIC, unsaturated iron binding capacity.
Includes dietary intake pattern, preferred food, frequency of eating out, use of canned foods, and use of plastic containers.
Eight phthalate metabolites: mono-benzyl phthalates, mono-n-butyl phthalates mono-isobutyl phthalates, mono-ethyl phthalates, mono-(2-ethylhexyl) phthalates, mono-(2-ethyl-5-hydroxyhexyl) phthalates, mono-(2-ethyl-5-oxohexyl) phthalates, and mono-isononyl phthalates.
Aflatoxin metabolites M1, B1, B2, G1, G2.